Type I Interferons and Natural Killer Cell Regulation in Cancer

被引：114
|
作者：
Mueller, Lena [1 ]
Aigner, Petra [1 ]
Stoiber, Dagmar [1 ,2 ]
机构：
[1] Ludwig Boltzmann Inst Canc Res, Vienna, Austria
[2] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria
来源：
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
关键词：
type I interferon; interferon signaling; natural killer cells; tumor surveillance; innate immunity; tumor microenvironment; anticancer therapy; APOPTOSIS-INDUCING LIGAND; ANTITUMOR IMMUNE-RESPONSES; HEMATOPOIETIC STEM-CELLS; DENDRITIC CELLS; NK-CELLS; T-CELL; DISTINCT REQUIREMENTS; SUPPRESSOR-CELLS; TUMOR-CELLS; ALPHA;
D O I：
10.3389/fimmu.2017.00304
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Type I interferons (IFNs) are known to mediate antitumor effects against several tumor types and have therefore been commonly used in clinical anticancer treatment. However, how IFN signaling exerts its beneficial effects is only partially understood. The clinically relevant activity of type I IFNs has been mainly attributed to their role in tumor immune surveillance. Different mechanisms have been postulated to explain how type I IFNs stimulate the immune system. On the one hand, they modulate innate immune cell subsets such as natural killer (NK) cells. On the other hand, type I IFNs also influence adaptive immune responses. Here, we review evidence for the impact of type I IFNs on immune surveillance against cancer and highlight the role of NK cells therein.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] Type I interferons induce autophagy in certain human cancer cell lines
    Schmeisser, Hana
    Fey, Samuel B.
    Horowitz, Julie
    Fischer, Elizabeth R.
    Balinsky, Corey A.
    Miyake, Kotaro
    Bekisz, Joseph
    Snow, Andrew L.
    Zoon, Kathryn C.
    AUTOPHAGY, 2013, 9 (05) : 683 - 696
  • [22] Biochemical effects of type I interferons on prostate cancer cell cycle.
    Hobeika, A
    Subramaniam, PS
    Johnson, HM
    FASEB JOURNAL, 1996, 10 (06): : 2018 - 2018
  • [23] T cell regulation of natural killer cells
    Kerdiles, Yann
    Ugolini, Sophie
    Vivier, Erie
    JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (06): : 1065 - 1068
  • [24] Regulation of the natural killer cell receptor repertoire
    Raulet, DH
    Vance, RE
    McMahon, CW
    ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 291 - 330
  • [25] Epigenetic regulation of natural killer cell memory*
    Lau, Colleen M.
    Wiedemann, Gabriela M.
    Sun, Joseph C.
    IMMUNOLOGICAL REVIEWS, 2022, 305 (01) : 90 - 110
  • [26] Molecular mechanisms of natural killer cell regulation
    Watzl, Carsten
    Urlaub, Doris
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 : 1418 - 1432
  • [27] Regulation of murine natural killer cell commitment
    Huntington, Nicholas D.
    Nutt, Stephen L.
    Carotta, Sebastian
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [28] Regulation of Murine Natural Killer Cell Development
    Goh, Wilford
    Huntington, Nicholas D.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [29] Regulation of adaptive immunity by type I interferons and serinephosphorylated STATI
    Pilz, Andrea
    Kratky, Wolfgang
    Decker, Thomas
    CYTOKINE, 2007, 39 (01) : 33 - 34
  • [30] Regulation of virally induced lung inflammation by type I interferons
    Johansson, C.
    IMMUNOLOGY, 2014, 143 : 21 - 21
12345